RDHL Stock Summary and Trading Ideas (Redhill Biopharma Ltd. - American Depositary Shares | NASDAQ:RDHL)

RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.

Redhill Biopharma Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol RDHL.

As of July 2, 2026, RDHL stock price declined to $0.81 with 34,898 million shares trading.

RDHL has a beta of 1.73, meaning it tends to be more sensitive to market movements. RDHL has a correlation of 0.07 to the broad based SPY ETF.

RDHL has a market cap of $4.22 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, RDHL traded as high as $12.50 and as low as $.26.

RDHL has underperformed the market in the last year with a return of -59.4%, while the SPY ETF gained +21.3%. In the last 3 month period, RDHL fell short of the market, returning +1.6%, while SPY returned +13.9%. However, in the most recent 2 weeks RDHL has outperformed the stock market by returning -0.2%, while SPY returned -0.3%.

RDHL support price is $.77 and resistance is $.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RDHL shares will trade within this expected range on the day.